Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000003478 | SCV000793442 | pathogenic | Polyglandular autoimmune syndrome, type 1 | 2017-08-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001091469 | SCV001247535 | pathogenic | not provided | 2019-08-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000003478 | SCV001385844 | pathogenic | Polyglandular autoimmune syndrome, type 1 | 2023-08-16 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 3314). For these reasons, this variant has been classified as Pathogenic. Disruption of the initiator codon has been observed in individuals with autosomal recessive autoimmune polyendocrinopathy syndrome (PMID: 16965330, 19758376, 20407228, 28446514, 28911151). This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the AIRE mRNA. The next in-frame methionine is located at codon 184. |
OMIM | RCV000003478 | SCV000023636 | pathogenic | Polyglandular autoimmune syndrome, type 1 | 2006-10-01 | no assertion criteria provided | literature only | |
Natera, |
RCV000003478 | SCV002083837 | pathogenic | Polyglandular autoimmune syndrome, type 1 | 2020-12-16 | no assertion criteria provided | clinical testing |